Ich stimme zu, dass diese Seite Cookies verwende. Weitere Informationen finden Sie unter unseren Datenschutzerklärungen .
X
Monk, B.
448  Ergebnisse:
OpenAccess-Volltexte X
Personensuche X
?
1

Updated efficacy and safety of lenvatinib (LEN) plus pembro..:

Colombo, N ; Makker, V ; Casado Herraez, A...
Annals Of Oncology.  , 2022
Link: https://hdl.handle.net/1..
 
?
2

Unilateral inguinofemoral lymphadenectomy in patients with ..:

Van der Kolk, W. L ; Van der Zee, A. G.J ; Slomovitz, B. M...
https://research.rug.nl/en/publications/eebc0bd5-c42d-4ba8-a478-15000d84b493.  , 2022
Link: https://hdl.handle.net/1..
 
?
3

Updated efficacy and safety of lenvatinib (LEN) plus pembro..:

Makker, V ; Colombo, N ; Casado Herraez, A...
Annals Of Oncology.  , 2022
Link: https://hdl.handle.net/1..
 
?
4

Updated efficacy and safety of lenvatinib (LEN) plus pembro..:

Makker, V ; Colombo, N ; Casado Herraez, A...
Annals Of Oncology.  , 2022
Link: https://hdl.handle.net/1..
 
?
5

A Randomized, Phase III Trial to Evaluate Rucaparib Monothe..:

Monk B.J ; Parkinson C ; Lim M.C...
Journal of Clinical Oncology.  , 2022
Link: https://doi.org/10.1200/..
 
?
6

Unilateral inguinofemoral lymphadenectomy in patients with ..:

Van der Kolk, W. L ; Van der Zee, A. G.J ; Slomovitz, B. M...
https://pure.au.dk/portal/en/publications/915a3c80-2234-4e65-b7d3-7a488d28e048.  , 2022
Link: https://pure.au.dk/porta..
 
?
7

Unilateral inguinofemoral lymphadenectomy in patients with ..:

Van der Kolk, W. L ; Van der Zee, A. G. J ; Slomovitz, B. M...
Gynecologic Oncology, 0090-8258, 2022, 167:1,.  , 2022
Link: http://urn.kb.se/resolve..
 
?
8

Efficacy and safety of niraparib in older patients (pts) wi..:

Valabrega, G ; Pothuri, B ; Oaknin, A...
Valabrega , G , Pothuri , B , Oaknin , A , Graybill , W , Sanchez , A B , Mccormick , C , Baurain , J-F , Hoskins , P , Denys , H , O'Cearbhaill , R E , Heitanen , S , Moore , R G , Knudsen , A O , Rouge , T D L M , Heitz , F , Levy , T , Li , Y , Gupta , D , Monk , B J & Gonzalez Martin , A 2020 , ' Efficacy and safety of niraparib in older patients (pts) with advanced ovarian cancer (OC): Results from the PRIMA/ENGOT-OV26/GOG-3012 trial ' , Annals of Oncology , vol. 31 , no. Suppl. 4 , 819P , pp. S619 . https://doi.org/10.1016/j.annonc.2020.08.958.  , 2020
Link: https://portal.findresea..
 
?
9

Patient-reported outcomes at discontinuation of anti-angiog..:

Chase, D.M ; Huang, H.Q ; Monk, B.J...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7780262/.  , 2020
Link: http://www.ncbi.nlm.nih...
 
?
10

Efficacy and safety of niraparib in older patients with adv..:

Heitz, F ; Valabrega, G ; Pothuri, B...
Heitz , F , Valabrega , G , Pothuri , B , Oaknin , A , Graybill , W , Sanchez , A B , McCormick , C , Baurain , J F , Hoskins , P , Denys , H , O'Cearbhaill , R E , Hietanen , S , Moore , R G , Knudsen , A O , Rouge , D L M T , Levy , T , Li , Y , Gupta , D , Monk , B J & Gonzalez-Martin , A 2020 , ' Efficacy and safety of niraparib in older patients with advanced ovarian cancer (OC): results from the PRIMA/ENGOT-OV26/GOG-3012 trial ' , Geburtshilfe und Frauenheilkunde , vol. 80 , no. 10 , pp. E220-E221 . https://doi.org/10.1055/s-0040-1718222.  , 2020
Link: https://portal.findresea..
 
?
11

Overall survival results of AGO-OVAR16: A phase 3 study of ..:

Vergote I ; du Bois A ; Floquet A...
info:eu-repo/semantics/altIdentifier/pmid/31519320.  , 2019
Link: http://hdl.handle.net/10..
 
?
12

A GCIG international survey: clinical practice patterns of ..:

Vercellino, G F ; Erdemoglu, E ; Lichtenberg, P...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7469255/.  , 2019
Link: http://www.ncbi.nlm.nih...
 
?
13

Quality of life is significantly associated with survival i..:

Phippen, N.T ; Secord, A.A ; Wolf, S...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5605439/.  , 2017
Link: http://www.ncbi.nlm.nih...
 
?
14

A phase 2, randomized, double-blind, placebo- controlled st..:

Monk, B. J ; Brady, M. F ; Aghajanian, C...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5406764/.  , 2017
Link: http://www.ncbi.nlm.nih...
 
?
15

A phase 2, randomized, double-blind, placebo- controlled st..:

Monk, B.J ; Brady, M.F ; Aghajanian, C...
info:eu-repo/semantics/altIdentifier/doi/10.1093/annonc/mdx049.  , 2017
Link: https://serval.unil.ch/n..
 
1-15